|
Sculptra®... a sculpting agent that restores volume to correct the signs of facial fat
loss
Sculptra® is an enduring treatment approved by the FDA for restoration and/or
correction of the signs of facial fat loss, or lipoatrophy,
in people with human immunodeficiency virus. It is the first FDA-approved product
of its kind for this condition.
Facial fat loss, or lipoatrophy, is the loss of fat beneath the skin, which can result
in sunken cheeks, indentations, and hollow eyes.
Sculptra® is a safe, synthetic, and biocompatible material that is injected below
the surface of the skin in the area of fat loss. It provides a gradual and significant
increase in skin thickness, improving the appearance of folds and sunken areas. No skin
testing is required.
Sculptra® has been safely used outside the United States since
1999 in over 150,000 patients under the trade names New-Fill™ and Sculptra®.
Find out what Sculptra® does.
|